Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c

Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.

You May Also Be Interested In

• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
• Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings